Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Genotoxicity of antitumor compound 3-bromopyruvate in the yeast Saccharomyces cerevisiae.

2015/17/D/NZ2/01985

Keywords:

3-bromopyruvate yeast DNA repair cell cycle checkpoints response to DNA damage

Descriptors:

  • NZ2_1: Molecular genetics

Panel:

NZ2 - Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology

Host institution :

Uniwersytet Wrocławski, Wydział Nauk Biologicznych

woj. dolnośląskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr Magdalena Cal 

Number of co-investigators in the project: 3

Call: SONATA 9 - announced on 2015-03-16

Amount awarded: 450 000 PLN

Project start date (Y-m-d): 2016-03-07

Project end date (Y-m-d): 2021-09-06

Project duration:: 66 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Mikroskop optyczny z możliwością obserwacji w kontraście fazowym wraz z kamerą (40 000 PLN)
  2. Termoblok z wytrząsaniem (13 000 PLN)
  3. Laptop wraz z oprogramowaniem MS Office oraz OS Windows a także z dyskiem zewnętrznym (3 500 PLN)
  4. Zestaw do elektroforezy żelowej białek z wyposażeniem i modułem do transferu mokrego oraz z zasilaczem (13 000 PLN)
  5. Urządzenie archiwizujące - zestaw komputerowy.

Information in the final report

  • Publication in academic press/journals (3)
  1. Mitochondrial Function Are Disturbed in the Presence of the Anticancer Drug, 3-Bromopyruvate
    Authors:
    Magdalena Cal, Irwin Matyjaszczyk, Karolina Filik, Rafał Ogórek, Young Ko and Stanisław Ułaszewski
    Academic press:
    International Journal of Molecular Sciences (rok: 2021, tom: 22, strony: 6640), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms22126640 - link to the publication
  2. Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma
    Authors:
    Niedźwiecka K., Dyląg M., Augustyniak D., Majkowska-Skrobek G., Cal-Bąkowska M., Ko YH., Pedersen PL., Goffeau A., Ułaszewski S.
    Academic press:
    Oncotarget (rok: 2016, tom: 40, strony: 65614-65626), Wydawca: Oncotarget
    Status:
    Published
    DOI:
    10.18632/oncotarget.11592 - link to the publication
  3. The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
    Authors:
    Magdalena Cal, Irwin Matyjaszczyk, Ireneusz Litwin, Daria Augustyniak, Rafał Ogórek, Young Ko, Stanisław Ułaszewski
    Academic press:
    Cells (rok: 2020, tom: 9, strony: 1161), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/cells9051161 - link to the publication